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ABSTRACT
Objective: To estimate physical and mental health
effects of the Eyjafjallajo ¨kull volcanic eruption on
nearby residents.
Design: Cross-sectional study.
Setting: The Icelandic volcano Eyjafjallajo ¨kull erupted
on 14 April 2010. The eruption lasted for about
6 weeks and was explosive, ejecting some 8 million
tons of ﬁne particles into the atmosphere. Due to
prevailing winds, the ash spread mostly to the south
and south-east, ﬁrst over the rural region to the south,
later over the Atlantic Ocean and Europe, closing
European air space for several days.
Participants: Residents (n¼207) of the most ash-
exposed rural area south and east of the volcano.
Methods: The study period was from 31 May to 11
June 2010. Participants were examined by a physician.
To ascertain respiratory health, standardised
spirometry was performed before and after the use of
a bronchodilator. All adult participants answered
questionnaires about mental and physical health, their
children’s health and the use of protective equipment.
Results: Every other adult participant reported
irritation in eyes and upper airway when exposed to
volcanic ash. Adults (n¼26) and children (n¼5) with
pre-existing asthma frequently reported worsening of
their symptoms. No serious health problems requiring
hospitalisation could be attributed to the eruption. The
majority of the participants reported no abnormal
physical or mental symptoms to the examining
physician. Compared to an age- and gender-matched
reference group, the ash-exposed participants reported
lower smoking rates and were less likely to have
ventilation impairment. Less than 10% of the
participants reported symptoms of stress, anxiety or
depression.
Conclusions: Short-term ash exposure was
associated with upper airway irritation symptoms and
exacerbation of pre-existing asthma but did not
contribute to serious health problems. The exposure
did not impair respiratory function compared to
controls. Outdoor use of protective glasses and face
masks was considered protective against irritation in
eyes and upper airway.
INTRODUCTION
On 14 April 2010, an explosive summit crater
eruption began in Eyjafjallajo ¨kull (Eyjafjalla
Glacier), a volcano that is situated in south
Iceland (ﬁgure 1). In the early phases of the
eruption, ﬁne-grained ash was ejected up to
10 km into the atmosphere, disturbing air
trafﬁc in Europe for days. In Iceland, the
rural regions south and south-east of the
volcano were heavily exposed to falling ash.
The volcano ejected some 250 million tons of
ash, of which 8 million tons of particles were
2.8e28 mm in diameter.
1e5 Particles with
a diameter of <10 mm are inhalable and can
compromise respiratory health. Despite the
falling ash that changed day to night, many
inhabitants, mostly farmers, remained in the
area to work on their farms and tend their
livestock.
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ARTICLE SUMMARY
Article focus
- Exposure to volcanic ash and gases can have
adverse effects on respiratory health.
- Natural hazards, such as volcanic eruptions, can
be stressful events.
- Value of preventive measures for those exposed
to a volcanic eruption.
Key messages
- The short-term effects of ash exposure were
associated with irritation in eyes and upper
airway and exacerbation of pre-existing asthma
but did not contribute to serious health problems
or impair respiratory function as compared to
controls.
- Participants with pre-existing respiratory and
mental conditions need special attention and
are more prone to developing symptoms
following exposure to volcanic eruptions and
volcanic ash.
- The use protective glasses and face masks
prevented or relieved irritation symptoms from
the eyes and upper airway.
Carlsen HK, Gislason T, Benediktsdottir B, et al. BMJ Open 2012;2:e000343. doi:10.1136/bmjopen-2011-000343 1
Open Access ResearchApart from the immediate life-threatening hazards
following a volcano eruption, such as pyroclastic ﬂows,
mudslides and glacial outburst ﬂoods, several other
health risks are associated with living close to an active
volcano.
6 Short-term exposure to volcanic gases can
trigger asthma attacks and has been associated with
respiratory morbidity and mortality and increased irri-
tation of the respiratory tract.
7 Exposures for longer time
periods to volcanic ash and gases have been associated
with increases in cardiovascular symptoms
8 and
increased rates of chronic bronchitis and other respira-
tory symptoms,
91 0also in children.
11 Symptoms of skin
and eye irritation have also been reported.
12 The
chemical and physical properties of volcanic ash vary
a great deal between eruptions and volcanoes, making it
difﬁcult to generalise about the toxicity of ash from
individual eruptions.
12
Volcanic eruptions are violent natural disasters that
impose a threat to health as well as to livestock and
property. During eruptions, the population may have to
be evacuated, depending on risk assessment, and
uncertainty and stress experienced during the eruption
can inﬂuence mental well-being.
13 14 The aims of this
study were to examine medically the most exposed
population and to evaluate possible acute physical and
mental health effects associated with the Eyjafjallajo ¨kull
eruption. In addition, the effectiveness of protective
measures taken against inhaling ash and eye exposure
was evaluated by asking the participants for their
subjective experience of the measures.
METHODS
The study area of the volcanic eruption
The volcanic eruption of the Eyjafjallajo ¨kull volcanic
system began on 20 March 2010 with a small ﬂank
eruption, which produced negligible ash. After a day of
no volcanic activity, an eruption started within the
Eyjafjallajo ¨kull caldera on 14 April.
15 This phase was
explosive, sending ﬁne-grained, phreatomagmatic ash
into the atmosphere. The eruption lasted some 6 weeks,
until the end of May 2010. Ash exposure around the
volcano was estimated using information about the
eruption plume from satellite images (coarse time reso-
lution), information about the emission intensity,
1 and
information from observations on the ground.
16 Model
calculations using FLEXPART
5 gave similar distribution
for the deposited ash, with maximum deposition around
1000 g/m
2 (near the vent of the volcano) and about
200 g/m
2 near Vı ´k.
4 During that time, the wind direc-
tion was predominantly west and north-west, therefore
most of the ash fall was to the south and south-east of the
volcano (ﬁgure 1). In this study, we included inhabitants
of the area between the River Markarﬂjo ´t and the village
of Vı ´k as they were most exposed. Most inhabitants are
farmers, and many also have income from tourism.
The volcanic ash
The ash was trachyandesitic, 58% silica by mass, but
contained very little quartz, and no cristobalite was
detected.
1e5 In ash samples collected during the ﬁrst
3 days of the eruption, upwards of 25% of particles by
mass were <10 mm in diameter (PM10) and therefore
inhalable. The fraction of ﬁne particles was lower for ash
ejected later in the eruption,
1 but still the amount of ash
produced was considerable, and the ﬁne-grained ash was
also easily resuspended. The concentration of airborne
particulate matter frequently exceeded the WHO
guideline values for PM10 during the eruption.
4
A network of diffusion tubes in the ground area
showed no evidence of fumigation by sulphur dioxide,
the predominant volcanic gas in the ash plume, in the
last 3 weeks of the eruption (Personal communication:
Peter Baxter, 2010).
Figure 1 Map of the study area, which reached from just west
of Eyjafjallajo ¨kull to Vı ´k in the east. The shading illustrates
duration and intensity of the ash plume. The darkest areas
represent an estimated ash deposition of >500 g/m
2, and
around Vı ´k, the deposition is estimated around 200 g/m
2.
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Strengths and limitations of this study
- The whole population living within a conﬁned area close to the
volcano was contacted, and the response rate was high (93%)
minimising the risk of selection bias, though some sensitive
individuals had probably left the area, and some older
individuals did not participate in the survey.
- Standardised methods were used in measuring respiratory
function, and questionnaires were also standardised, allowing
for comparisons with other studies.
- Results from the spirometry were compared to those from an
age- and gender-matched Icelandic control group from
a previous study, which had been performed using identical
methods.
- The population was small (N¼207), and due to stressful
circumstances during the test period, not all participants
completed the questionnaire, which limited the statistical
power of our analyses.
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptionTarget population and recruitment
During the eruption, some 223 individuals lived in the
study area and were exposed to ash fall. All the inhabi-
tants were invited to a medical examination during the
time period 31 Maye11 June 2010. An announcement
was put up in local ofﬁcial buildings and information
given on radio and TV news. Also, inhabitants were
contacted by telephone by staff from the two local
primary healthcare centres in the area. The majority of
participants were examined at temporary medical ofﬁces
at a community centre or at a primary healthcare centre;
a few were examined in their homes.
Medical and psychological examination
A physician interviewed and examined all participants.
The physicians in charge were specialists in family
medicine and respiratory medicine. Former and present
physical and psychological health was explored. Partici-
pants were asked if they experienced any change in
health or new symptoms that they related to the ash and
the volcanic eruption. The medical history of young
children was obtained from their parents. In case of
abnormal ﬁndings, the participants were referred to
their Primary Health Care Centre for further examina-
tion and treatment.
Spirometry
The forced expiratory volume in one second (FEV1) and
the forced vital capacity (FVC) values were obtained by
spirometry in all participants 5 years or older, according
to the American Thoracic Society criteria in the same
way and by the same ﬁeldworkers as had conducted the
Burden of Obstructive Lung Disease (BOLD) multi-
centre study in Iceland.
17 18 The spirometry was
conducted by trained and certiﬁed personnel, and the
medical examination was conducted by doctors, all from
the Landspitali University Hospital.
Brieﬂy, testing was conducted with the participant in
a sitting position wearing a nose clip and a disposable
mouthpiece using the NDD Easy One spirometer
(NDD Medizintechnik, Zurich,S w i t z e r l a n d ) .P r e b r o n -
chodilator and postbronchodilator tests were carried
out, with separate measurements performed before
and $15 min after two puffs of salbutamol (200 mg).
The primary reference equations used are derived from
the third United States National Health and Nutr-
ition Examination Survey (NHANES III) for adult
Caucasians.
19
The criteria for chronic obstructive pulmonary disease
(COPD) are deﬁned by the Global Initiative of Chronic
Obstructive Lung Disease.
17 COPD GOLD stage I was
deﬁned as FEV1/FVC ratio <0.7 after bronchodilation
and GOLD stage II as FEV1/FVC ratio <0.7 and FEV1
#80% predicted after bronchodilation. Reversibility of
airway obstruction was calculated as a change in FEV1
and expressed as a change in percentage (Δ%).
For analysis of the spirometry results in those older
than 40 years, a subset of the BOLD cohort
18 was used as
a control group, with three age- and gender-matched
controls from the BOLD (random general) population
for each participant exposed to volcanic ash.
Questionnaires
Participants older than 18 years were asked to ﬁll out
questionnaires with questions about physical health,
mental health, exposure to volcanic ash, experience of
earthquakes, rumbling and smell from the volcano, and
use of protective face masks and glasses. If necessary, the
questionnaires were read to them by researchers.
Respiratory health before the eruption was assessed by
the European Community Respiratory Health Survey
(ECRHS) II Questionnaire.
20 From the main ECRSH
Questionnaire, we used questions about wheeze, cough
and phlegm prevalence, history of respiratory- and heart
disease (questions number 1e3, 6e10 and 14, and
question 7 from the screening questionnaire).
The participants were also asked if they had experi-
enced other respiratory or eye symptoms, muscular pain,
fatigue, nausea, headache, stomach pain or insomnia
before and/or after the eruption started. If the symp-
toms had started after the eruption, they were asked to
quantify how much these symptoms affected their daily
life on a 3-point scale (rather little, rather much and very
much).
Parents answered seven questions about respiratory
symptoms, headache, stomach ache, insomnia, anxiety,
depression and behavioural changes in children younger
than 18 years. If these symptoms had started after the
eruption, they were asked to quantify them on a three-
level scale.
There were also questions about medical emergencies,
use of medication, injuries, and accidents related to the
eruption.
Mental health was assessed with three different
psychometric scales, which all had previously been
translated into Icelandic and used in other studies.
When measuring psychological morbidity in relationship
with the eruption, we used the General Health Ques-
tionnaire (GHQ-12),
21 22 the Depression Anxiety Stress
Scale (DASS),
23 and the Post-Traumatic Stress Disorder
(PTSD) Symptom Scale, Self-Report version (PSS-SR).
24 25
Each questionnaire was evaluated, and, if inadequately
answered, excluded.
For GHQ-12, a score of more than 2 was considered
indicative of experiencing more mental distress than
usual (Bimodal score).
21
For PSS-SR, a score of more than 14 considered
indicative of likelihood of PTSD symptoms in the
participants.
24 25
For DASS, a score was given for each of the three
dimensions addressed in the questionnaire. A score of
more than 10 for depression, 8 for anxiety, and 15 for
stress indicated symptom severity, from mild to extreme,
as deﬁned by Lovibond and Lovibond.
23 DASS and PSS-
SR questionnaires were not administered on the ﬁrst day
of the study, but participants were given the option of
ﬁlling out the questionnaires and mailing them.
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptionParticipants were asked how they had experienced ash
fall, heard or been awakened by noise from the volcano,
felt earthquakes, smell or limited vision outside due to
ash fall at their homes; how many days they had to stay
inside because of ash fall; how many hours they usually
worked outdoors and if they had used protective
equipment. Finally, participants were asked if they had
received help or services from a number of organisations
and institutions, and if they were satisﬁed with it.
Smoking history was investigated by asking participants
if they had ever smoked, and if they were current
smokers. Based on this information, the participants
were classiﬁed into never-smoker, former smoker and
current smoker.
Statistical analysis
All data were entered into a database by one observer.
The analysis was mainly descriptive, and the primary
outcome measure was prevalence in percentage (%) of
the total number of answers in the given category. In
comparisons between groups, we used Student t test and
c
2 test. Individuals with incomplete data were not
excluded from the study, but non-replies to any single
questions were excluded from individual analyses. We
used SPSS software V.18
26 and R.
27
RESULTS
Altogether 207 out of 223 individuals (93%) who lived in
the study area at the time of the eruption participated in
the study. Local health workers, who recruited the
participants, reported that inhabitants of two of about 80
farms had refused to participate, and 14 individuals who
had initially signed up did not participate.
The most common reason for non-participation
reported to the recruiters was either ‘being busy’, ‘not
having any health problems’ or ‘old age’ (reported by
relatives). Of the 207 participating residents, 40 were
younger than 18 years. Most of them, 202 (98%) were
medically examined, 164 adults and 38 children. The
same proportion was tested with spirometry, and 156
adults were tested both before and after bronchodila-
tion. All adults received questionnaires about symptoms
and general health (GHQ-12). PSS-SR and DASS were
administered to 150 people. Main demographic charac-
teristics, symptom, and smoking rates reported by adults
are shown in table 1. The survey included 40 children
younger than 18 years, of which 21 (53%) were girls.
The age distribution of all participants is given in
ﬁgure 2.
Physical examination
The physician’s judgement was that 126 (62%) of the
participants were healthy. In the physician interview, 26
(13%) of adults reported history of asthma or other
chronic respiratory diseases, 32 (16%) reported symptoms
and signs other than respiratory and 27 (13%) partici-
pants indicated a history of mental symptoms. Asthma
rates reported to physicians were similar to those reported
in questionnaires. Of those with a history of asthma or
other respiratory diseases, 38% had a normal spirometric
test, but 39% reported worsening of the disease when
exposed to ash (table 1). Some reported to physicians that
upper respiratory symptoms subsided when avoiding
exposure by staying inside, wearing dust masks, and also
that falling ‘fresh’ ash was more bothersome than ‘older’
ash re-suspended by wind. Farming was reported as the
main occupation (63%) of adult participants.
Spirometry
Among the 202 participants who underwent spirometry,
37 (18%) were found to have impaired respiratory
function by the examining physician.
Table 1 Demographic characteristics and questionnaire-reported symptoms of participants who all lived close to the
Eyjafjallajo ¨kull volcano (n¼167)
All Men Women
N (%) 83 (50) 84 (50)
Mean age6SD (years) 52617 54618 50617
BMI6SD (kg/m
2) 30.067 29.165 30.868
Smoking, n (%)
Never 103 (62) 53 (64) 50 (60)
Former 34 (20) 18 (22) 16 (19)
Current 24 (14) 11 (13) 13 (14)
Self-reported asthma or COPD*, n (%) 28 (17) 10 (12) 18 (21)
Respiratory symptoms, n (%)
Throat and upper airway irritation or dryness 83 (50) 35 (42) 48 (57)
Cough 58 (35) 28 (34) 30 (35)
Shortness of breath or tightness of chest 43 (26) 20 (24) 23 (27)
Other symptoms, n (%)
Eye irritation 41 (25) 17 (20) 24 (29)
Headaches 15 (9) 8 (10) 7 (8)
Nausea and stomach aches 12 (7) 7 (8) 5 (6)
*As reported in questionnaires (‘Have you ever been diagnosed with asthma or COPD’).
BMI, body mass index; COPD, chronic obstructive pulmonary disease.
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptionParticipants aged 40 years or older had on average
a higher FEV1 than the reference group (p¼0.003), and
they also showed less airﬂow reversibility (p<0.0001).
The rates of chronic cough and phlegm were similar in
the study participants and the reference group (8%e
10%). Smoking was more common in the reference
group than the volcano-exposed participants (p<0.01).
After bronchodilation, 20% of those aged 40 years or
older fulﬁlled the criteria for COPD stage I or higher,
which was identical to that found among the general
population reference group (table 2).
18
The 35 children who were tested with spirometry had
a normal per cent of predicted FEV1 (102%619%;
mean, one SD) and FVC (104%617%). Altogether four
had FEV1% predicted lower than 85%; two of these had
pre-existing asthma and revealed symptoms when
examined (FEV1 48% and 76%, respectively), the other
two were previously healthy, but both had symptoms of
upper airway virus infection (FEV1 71% and 81%,
respectively) when examined.
Questionnaires
Almost half of the adult participants (43%) experienced
symptoms from the upper airways and eyes during the
ash fall. Almost everybody or 153 of 161 (96%) found
facial mask and glasses protective against respiratory and
Figure 2 Age distribution of the
study participants (n¼207) from
the Eyjafjallajo ¨kull area
investigated from 31 May to 11
June 2010.
Table 2 Spirometry results, smoking status, reported chronic respiratory diseases and symptoms among participants aged
>40 years compared to an age- and gender-matched reference group from the general population
Participants (n[128), Controls (n[384),
Spirometry Mean±SD Mean±SD p (t test)
FEV1 % predicted* 94615 90617 0.003
FVC % predicted 98615 95614 0.105
FEV1/FVC % predicted 96699 3 611 0.004
ΔFEV1 (% increase after bronchodilation) 3674 67 <0.000
COPD n (%) n (%) p (c
2 test)
GOLD stage I or highery 25 (20) 77 (20) 1
GOLD stage II or higher 15 (12) 42 (11) 0.87
Self-reported
Smoking
Current 19 (15) 154 (40) 0.00*
Former 31 (24) 159 (41)
Never 76 (59) 71 (18)
Ever asthma 21 (20) 74 (19) 0.30
Ever COPD 3 (2) 6 (2) 0.70
Chronic phlegmz 11 (8) 38 (10) 0.61
Chronic coughz 11 (8) 43 (11) 0.33
*Predicted values from the National Health and Nutrition Examination Survey cohort.
yGOLD stage I COPD, FEV1/FEV1 <0.7; GOLD stage II COPD, FEV1/FEV1 <0.7 and FEV1 <80% predicted.
zHistory of cough or phlegm 3 months or more every year.
ΔFEV1, increase in FEV1 % predicted after use of bronchodilation; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory
volume in one second; FVC, forced vital capacity.
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptioneye symptoms when staying outdoor during ash fall. All
participants of the study were exposed to ash fall at their
homes, and almost all (88%) had to stay inside at least
1 day and one third (34%) for 6 days or more, which
may explain some of the mental distress and child
behavioural problems. Also, avoiding exposure by
staying in the well-isolated houses may have kept
symptom rates down. Almost everyone (98%) had heard
the explosions from the mountain at their home, and
53% had woken up at night because of noise, but there
was no obvious geographical pattern to this. The most
common self-reported symptoms in adult participants
are shown in table 1. Men and women had similar rates
of symptoms, except that women tended to report
more throat and upper airway irritation (p¼0.06,
Student t test).
Women reported more frequently mental health
deterioration than men, according to the GHQ and
DASS, and the highest rates were found in those between
35 and 49 years of age (table 3). Symptoms of post-
traumatic stress syndrome (PSS-SR) were found in 7% of
participants and were more common among women
than men and in those slightly older (50e64years old).
Very little effect on mental health was reported in the
age group 18e34 years.
Table 4 shows the proportions of participants experi-
encing mental distress by level of exposure (experience
of the volcanic eruption). Experiencing a feeling of
helplessness or fear for the lives of others or oneself
during the eruption period was associated with higher
rates of likely PTSD symptoms. The frequency of mental
distress (as measured by the GHQ) was signiﬁcantly
(p<0.05) higher in those who had been awakened by
noise.
Symptoms of depression and anxiety (DASS) were
more common among those who had experienced
earthquakes and had thought that their lives were in
danger (table 4).
Many children of school age were not in the area
during the heaviest ash fall. A boarding school outside
the affected region invited the Eyjafjallajo ¨kull children
to stay for some weeks. By the time the health survey was
carried out, most were in the area. Nevertheless, 13
(28%) of parents reported in the questionnaires that
their child had experienced throat or upper airway irri-
tation symptoms (data not shown). Eight (13%)
reported headaches, while three parents (7%) reported
that their child or children had had nausea or stomach
pain during the eruption. Of the 40 participating chil-
dren, ﬁve had a history of asthma and they all reported
in the medical interview that they had had more symp-
toms during the ash fall and needed more antiasthmatic
medication than usual. Regarding mental distress, 39%
of participants with children reported increased worries
or anxiety in their children, 18% reported increased
behaviour problems and 16% reported sleep-related
problems.
DISCUSSION
In a well-deﬁned rural population that had been
exposed to volcanic ash particles with a substantial
inhalable fraction for several weeks during the Eyjafjal-
lajo ¨kull eruption, we found only a small degree of
physical health impairments soon after the eruption. No
hospital admissions, fatalities or life-threatening or
serious symptoms or diseases that could be attributed to
the eruption were found in this study cohort. From the
answers to the questionnaires, we could conclude that
compared to the general population sample from the
BOLD study, the study participants reported a similar
prevalence of respiratory symptoms and obstructive lung
disease. Some symptoms of mental distress were found in
this study.
In our study, we contacted the whole population living
closest to the volcano and had a high participation rate
(93%). According to the recruiters, some non-participators
Table 3 Mental symptoms following the eruption of Eyjafjallajo ¨kull
Likelihood of PTSD* General Healthy Depressionz Anxietyz Stressz
Number of valid replies 138 151 132 130 133
Casesx 10 (7%) 59 (39%) 9 (7%) 11 (8%) 9 (7%)
Women 8/62 (13%) 38/78 (49%) 6/71 (8%) 8/69 (12%) 7/71 (10%)
Men 2/76 (3%) 21/71 (30%) 3/62 (5%) 3/61 (5%) 2/62 (3%)
Age categories
18e34 0/27 (0%) 9/32 (29%) 0/27 (0%) 1/27 (4%) 0/26 (0%)
35e49 3/36 (8%) 24/39 (62%) 5/35 (14%) 5/33 (15%) 6/34 (17%)
50e64 6/41 (15%) 18/47 (38%) 3/39 (8%) 3/40 (8%) 2/40 (5%)
>64 1/34 (3%) 8/33 (24%) 1/31 (3%) 2/30 (7%) 1/33 (3%)
Lived in the evacuation zone{
Yes 4/59 (7%) 26/69 (38%) 6/58 (10%) 7/57 (12%) 5/59 (8%)
No 6/79 (8%) 33/82 (40%) 3/75 (4%) 4/73 (5%) 4/73 (5%)
*Derived from the Post-Traumatic Stress Disorder (PTSD) Symptom ScaleeSelf Report (PSS-SR).
yDerived from the General Health Questionnaire (GHQ-12).
zDerived from the Depression Anxiety Stress Scale (DASS).
xThose who scored above the cut-off for the various scales.
{Some areas were evacuated in the ﬁrst days of the eruption due to ﬂood risks.
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptionreported not having any health problems, so the
symptom rates presented here may be overestimated.
There may also be a recall bias, so that those who are
worried about their health are more likely to participate
and recall symptoms. On the other hand, some vulner-
able individuals may have chosen not to participate or
had left the most affected area, which may cause us to
underestimate the symptom rates.
To facilitate comparisons with other studies, we used
standardised methods in both the medical examinations
and questionnaires, as well as the spirometry in this
survey. However, the population is small (N¼207, of
which 167 were adults) and due to stressful circum-
stances during the test period, not all participants
completed the questionnaire, which limited the statis-
tical power of our analyses.
The participants from the Eyjafjallajo ¨kull area had
better lung function than the general population
sample, most likely due to a much lower prevalence of
smoking. They also had less obstructed airways when
tested again after use of a bronchodilator, probably
because those with asthma had already increased their
bronchodilator treatment during the ash fall. Also, the
general population reference sample lived in urban and
suburban areas, whereas the Eyjafjallajo ¨kull area is
predominantly rural. The children had normal spirom-
etry measurements. Previous studies have not found
changes in lung function in children after volcanic ash
exposure, but asthma hospitalisation rates have been
seen to increase after several eruptions,
11 12 and
a doseeresponse has also been found in a Japanese study
of asthmatic adults who were exposed to volcanic ash.
28
Intermittent symptoms in the eyes and upper respi-
ratory organs were very common, but they could be
prevented by wearing eye protection and face masks, or
avoiding exposure by staying inside. Facial masks and
glasses for eye protection were made widely and freely
available by the public health authorities. These
protective equipment were in plentiful supplies
purchased for the swine ﬂu epidemic the previous year.
Icelandic houses are generally quite well insulated with
windows that shut tightly and seemed to offer some
protection.
It was recorded in several of the medical examination
reports that people found the ash more irritating in the
beginning of the eruption, perhaps because fresh ash
particles can have chemical compounds on the surface,
which are later washed away.
2 3
In a study of the ash from Eyjafjallajo ¨kull, Horwell
et al
2 found most samples to have little potential for
damaging health. The ash contained a negligible
amount of crystalline silica, and though one sample
showed some cytotoxicity in in vitro studies, the report
concluded that the ash was unlikely to have an effect at
the levels to which people were actually exposed.
The ﬁrst results from a study of lung tissue samples
and samples from the gastrointestinal tract of animals
brought to slaughter from the affected area in the
autumn of 2010 did not reveal any signiﬁcant
pathology.
29
Table 4 Mental symptoms and experiences during the eruption of Eyjafjallajo ¨kull
Likelihood of PTSDy
(n[138)
General
healthz (n[151)
Depressionx
(n[132)
Anxietyx
(n[130)
Stressx
(n[133)
Exposure at residence (‘From your residence, did you experience any of the following?’)z
Was awakened by noise (n¼157)
Yes 5/66 (8%) 38/75 (51%)* 3/63 (5%) 6/64 (9%) 3/63 (5%)
No 5/63 (8%) 16/66 (24%) 5/61 (8%) 4/58 (7%) 5/60 (8%)
Felt earthquakes (n¼155)
Yes 5/42 (12%) 27/51 (53%) 2/39 (5%)* 3/38 (8%) 2/39 (5%)*
No 4/85 (5%) 27/89 (30%) 5/84 (6%) 7/83 (8%) 5/84 (6%)
Traumatic experiences (‘Did you during the eruption.’)
Think your life was in danger (n¼144)
Yes 1/6 (17%)* 2/4 (50%) 1/5 (20%)* 0/5 (0%) 1/4 (25%)
No 8/126 (6%) 42/123 (34%) 8/123 (7%) 11/120 (9%) 7/123 (6%)
Think that someone else’s life was in danger (n¼139)
Yes 4/19 (21%)* 9/16 (56%) 3/18 (17%) 3/17 (29%) 3/17 (18%)*
No 5/108 (5%) 33/107 (31%) 5/105 (5%) 6/103 (6%) 4/105 (4%)
Feel helpless (n¼143)
Yes 9/30 (30%)* 20/27 (74%)* 8/30 (27%)* 8/29 (28%)* 7/28 (25%)*
No 0/101 (0%) 24/100 (24%) 1/98 (1%) 3/96 (3%) 1/99 (1%)
Feel afraid (n¼142)
Yes 4/17 (24%)* 10/17 (59%)* 5/18 (28%)* 4/16 (25%)* 3/17 (18%)
No 5/113 (4%) 34/108 (31%) 4/108 (4%) 6/107 (6%) 5/108 (5%)
In all fractions the nominator refers to those who scored above the cut-off for the various scales.
*Signiﬁcant difference in exposure rates between cases and non-cases (p<0.05 in a c
2 test).
yDerived from the Post-Traumatic Stress Disorder (PTSD) Symptom ScaleeSelf Report (PSS-SR).
zDerived from the General Health Questionnaire (GHQ-12).
xDerived from the Depression Anxiety Stress Scale (DASS).
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Early health effects of the Eyjafjallajo ¨ kull 2010 eruptionDuring the ﬁrst days of the eruption, precautions for
individuals with respiratory disease were issued
throughout much of Europe, both by national health
authorities but also by the WHO.
30 Symptom surveil-
lance studies, however, have shown a slight increase in
the number of individuals on the European continent
seeking medical help for certain symptoms in the period
when the region was affected by ash.
31 32
In our study, 39% of participants reported some
symptoms of mental distress, as measured by the GHQ. A
high GHQ score was associated with feeling helpless or
afraid or being awakened by noises from the volcano.
The rate of GHQ cases in this study was more than twice
as many as in a 2004 study of Icelandic farmers where
17% scored above the reference value for mental distress
in the GHQ.
33 However, in a Japanese study of a popu-
lation exposed to a volcanic eruption, 66% were found
to suffer from mental distress, but this population had
been evacuated and were unable to return to their home
region for years.
14 Only half of the participants in this
study population were evacuated, and then only for a few
days.
The proportion of participants who exhibited symp-
toms of post-traumatic stress (7%) was similar to that
found following a large earthquake in the south of
Iceland in 2008.
34 When the eruption was still active,
there were substantial disturbances in people’s daily
routine. Some of the fatigue and stress indicated by the
high prevalence of mental distress may be attributed to
the increased workload during the eruption and at the
same time the uncertainty about one’s own health, the
health of others, the livestock and the future. In addi-
tion, our results showed that increased mental distress
might partly be explained by the extent of experience of
volcanic phenomena, as it was associated with having
experienced earthquakes related to the eruption or
experiencing threat to one’s own life or that of others.
On the other hand, those who are distressed may expe-
rience these phenomena more strongly during an erup-
tion. Information about the possible health effects of the
ash was needed for the affected individuals. Therefore,
early in the eruption, collaboration was established with
national as well as international experts from the WHO
and EU, and the International Volcanic Health Hazards
Network, whose pamphlets were translated into Icelandic
and distributed widely.
35 Trauma response teams on
behalf of the Red Cross were present in the evacuation
and community centres, and a number of community
meetings were held to inform the affected population.
CONCLUSIONS
During the time when volcanic ash was falling from the
Eyjafjallajo ¨kull eruption, the majority of participants
experienced symptoms from eyes and upper airways.
Those with underlying obstructive lung disease were
particularly vulnerable; half of the asthmatic adults and
all the asthmatic children had more pronounced symp-
toms during the eruption.
Our results indicate that public health measures were
effective in relieving symptoms. Recommendation to
avoid exposure by either staying inside or wearing dust
protection masks and glasses when outdoors during the
ash fall or storms may have contributed to mitigation of
irritation and symptoms.
During a volcanic ash fall, intensive medical attention
should be aimed at vulnerable individuals with under-
lying respiratory diseases and known mental disorders.
Little is known about long-term health effects of
exposure to volcanic ash, but continuous surveillance
and research is necessary as the ash is likely to remain in
the environment for some years to come. A follow-up
study would be helpful in interpreting the spirometry
results, but no severe health outcomes could be associ-
ated with the eruption in this study.
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